- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CLOV
Recent news which mentions CLOV
Tickers
CLOV
From InvestorPlace
7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio
February 23, 2022
From InvestorPlace
IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist
February 22, 2022
From InvestorPlace
Thinking About Buying Stock In Clover Health, Jumia Or Lemonade?
February 22, 2022
From Benzinga
5 Upcoming SPACs to Watch in 2022
February 16, 2022
From InvestorPlace
A Buyout May Be the Best Hope for Clover Health Now
February 08, 2022
From InvestorPlace
10 Fintech Stocks To Own Until 2032 and Beyond
February 08, 2022
From InvestorPlace
SoFi Gets Bank License, But That’s Not Necessarily a Good Thing
February 04, 2022
From InvestorPlace
AMD Stock Price Predictions: Why Analysts See A Bright Future for Advanced Micro Devices
February 02, 2022
From InvestorPlace
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 02, 2022
From Benzinga
10 Biggest Price Target Changes For Wednesday
February 02, 2022
From Benzinga
7 Worst SPACs for Smart Investors to Skip in 2022
January 26, 2022
From InvestorPlace
At Below $3 Clover Health Stock May Be Worth It as a Moonshot
January 24, 2022
From InvestorPlace
Clover Health Stock Remains a High-Risk High-Reward Play
January 24, 2022
Tickers
CLOV
From InvestorPlace
Tickers
CLOV
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
From Benzinga
From Benzinga
From InvestorPlace
Camber Energy, Clover Health, Globalstar Stocks Continue Lower In Key Trend: Will The Bloodbath End?
January 14, 2022
From Benzinga
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet
January 14, 2022
From InvestorPlace
Polestar Looks Like the Right EV Stock At the Wrong Time
January 13, 2022
From InvestorPlace
RCL Stock Pressured by Hindenburg Short: 7 Things to Know
January 10, 2022
From InvestorPlace
From InvestorPlace
DeskTop Metal Shares Are Still Off Limits to Buyers
January 07, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
The Two Faces of Clover Health
January 06, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.